MétaCan
Menu
Back to cohort

North American patterns of care in clinical stage I testicular cancer from SWOG S1823.

2024· article· en· W4391333745 on OpenAlexaffabout
Antoine Morin Coulombe, Sarah Colby, Jennifer King, Marian L. Neuhouser, Banu Arun, Siamak Daneshmand, Andrea Harzstark, Kathryn B. Arnold, Craig R. Nichols, Lucia Nappi

Bibliographic record

VenueJournal of Clinical Oncology · 2024
Typearticle
Languageen
FieldMedicine
TopicTesticular diseases and treatments
Canadian institutionsBC Cancer AgencyCentre hospitalier universitaire de Québec
Fundersnot available
KeywordsMedicineTesticular cancerOncologyCancerStage (stratigraphy)Internal medicineGynecology

Abstract

fetched live from OpenAlex

509 Background: SWOG/CCTG S1823/GCC-001 is a non-interventional translational prospective cohort investigation with a primary endpoint of defining pre-treatment operational characteristics of the liquid germ cell cancer biomarker microRNA 371a-3p in predicting the presence of active germ cell malignancy. Opened in June 2020, 813 of the projected 956 patients have been registered with anticipated completion of accrual in early 2024. While analysis of the final endpoint awaits complete accrual and sufficient follow-up, S1823 creates a rich template of baseline clinical information and real-world treatment. Herein, we report baseline patterns of care in modern day real-world care delivery for Clinical Stage I (CSI) germ cell tumors across academic and community practices in North America. Methods: Data is obtained from case report forms and source documents for 547 S1823 enrollees with CSI seminoma or nonseminoma. Aggregate baseline clinical data unrelated to the primary endpoint are described to understand baseline clinical characteristics and management recommendations for CSI germ cell tumors. Results: Clinical characteristics and management recommendations for CSI are described in the table. The leading contributor to date is the Kaiser Permanente NCI NCORP followed by Canadian Institutions which together make up 38% of accruals from top level institutions. The majority of these largely young males were overweight or obese (67%). S1823 did not stipulate management which was at the discretion of local institutions/investigators. Active surveillance is the dominant strategy in both CSI seminoma and nonseminoma (85% overall). In CSI seminoma, adjuvant treatment with radiation is very rare (1/547) and adjuvant treatment with single agent carboplatin (1 or 2 cycles) is uncommon (4%). In CSI nonseminoma, adjuvant retroperitoneal lymph node dissection is also uncommon (3%) as is adjuvant chemotherapy with BEP X 1 or 2 (6%). Conclusions: In this large prospective multi-institutional observational cohort, surveillance appears to be the predominant management strategy for CSI germ cell tumors with very limited use of adjuvant chemotherapy or RPLND and virtual elimination of recommendation for radiation therapy for seminoma. Clinical trial information: NCT04435756 .[Table: see text]

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.133
Threshold uncertainty score0.265

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.004
Science and technology studies0.0010.000
Scholarly communication0.0010.000
Open science0.0010.001
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0070.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.087
GPT teacher head0.510
Teacher spread0.423 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2024
Admission routes2
Has abstractyes

Explore more

Same venueJournal of Clinical OncologySame topicTesticular diseases and treatmentsFrench-language works237,207